ANURAS Stock Overview
Engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Anupam Rasayan India Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹731.55 |
| 52 Week High | ₹1,106.30 |
| 52 Week Low | ₹672.80 |
| Beta | 0.21 |
| 11 Month Change | 0.70% |
| 3 Month Change | -9.39% |
| 1 Year Change | -21.83% |
| 33 Year Change | -9.77% |
| 5 Year Change | n/a |
| Change since IPO | 38.87% |
Recent News & Updates
Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
Nov 18
Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02Recent updates
Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
Nov 18Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02Time To Worry? Analysts Just Downgraded Their Anupam Rasayan India Ltd (NSE:ANURAS) Outlook
Aug 24Anupam Rasayan India Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 17Anupam Rasayan India's (NSE:ANURAS) Shareholders Have More To Worry About Than Only Soft Earnings
May 26Analyst Estimates: Here's What Brokers Think Of Anupam Rasayan India Limited (NSE:ANURAS) After Its Full-Year Report
May 22What You Can Learn From Anupam Rasayan India Ltd's (NSE:ANURAS) P/E
Dec 30Anupam Rasayan India (NSE:ANURAS) Might Have The Makings Of A Multi-Bagger
Nov 03Is Now The Time To Put Anupam Rasayan India (NSE:ANURAS) On Your Watchlist?
Jul 13Anupam Rasayan India's (NSE:ANURAS) Returns On Capital Are Heading Higher
Jun 24We Ran A Stock Scan For Earnings Growth And Anupam Rasayan India (NSE:ANURAS) Passed With Ease
Apr 06Earnings Update: Here's Why Analysts Just Lifted Their Anupam Rasayan India Ltd. (NSE:ANURAS) Price Target To ₹988
Jul 28Anupam Rasayan India's (NSE:ANURAS) Promising Earnings May Rest On Soft Foundations
May 20If You Like EPS Growth Then Check Out Anupam Rasayan India (NSE:ANURAS) Before It's Too Late
May 13Returns At Anupam Rasayan India (NSE:ANURAS) Appear To Be Weighed Down
Mar 31Investors Interested In Anupam Rasayan India Limited's (NSE:ANURAS) Earnings
Mar 07Shareholder Returns
| ANURAS | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 0.3% | -4.2% | -3.4% |
| 1Y | -21.8% | 11.1% | 27.0% |
Return vs Industry: ANURAS underperformed the Indian Chemicals industry which returned 11.1% over the past year.
Return vs Market: ANURAS underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| ANURAS volatility | |
|---|---|
| ANURAS Average Weekly Movement | 2.7% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: ANURAS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ANURAS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,896 | Gopal Agrawal | www.anupamrasayan.com |
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients.
Anupam Rasayan India Ltd Fundamentals Summary
| ANURAS fundamental statistics | |
|---|---|
| Market cap | ₹80.38b |
| Earnings (TTM) | ₹699.03m |
| Revenue (TTM) | ₹12.37b |
115.0x
P/E Ratio6.5x
P/S RatioIs ANURAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANURAS income statement (TTM) | |
|---|---|
| Revenue | ₹12.37b |
| Cost of Revenue | ₹5.14b |
| Gross Profit | ₹7.23b |
| Other Expenses | ₹6.53b |
| Earnings | ₹699.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.36 |
| Gross Margin | 58.46% |
| Net Profit Margin | 5.65% |
| Debt/Equity Ratio | 43.0% |
How did ANURAS perform over the long term?
See historical performance and comparison